New therapies and combination regimens may allow a more tailored approach.
Chelsey Lindner, PharmD, BCOP
Advertisement
Articles by Chelsey Lindner, PharmD, BCOP
It is important to promote the ongoing development of best practices for integrated specialty pharmacies in academic health systems.
Advertisement
Latest Updated Articles
Assessing the Landscape of HER2+ Breast Cancer TreatmentApril 18th 2022
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Priority Review to Zanubrutinib Plus Rituximab for Previously Untreated MCL
2
Frontline Immunotherapy Options in NSCLC: Are Checkpoint Inhibitors Interchangeable?
3
What Drives First-Line Immunotherapy Selection in NSCLC? Data, Payers, and Habit
4
AHA 2026: Insights on Oral PCSK9, Survodutide, and HF Care Come to Chicago
5